Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Closes Second and Final Tranche of Private Placement

GlobeNewswire July 5, 2018

DIAGNOS Broadens its Collaboration with the Government of Mexico

GlobeNewswire July 4, 2018

DIAGNOS Provides Financing Updates

GlobeNewswire June 29, 2018

DIAGNOS Hires Investor Relation Firm Momentum Public Relations and Provides Financing Update

GlobeNewswire June 14, 2018

DIAGNOS Announces the Availability of its New CARA High Blood Pressure Risk Assessment Based on its FLAIRE Artificial Intelligence Platform

GlobeNewswire June 12, 2018

REMINDER: DIAGNOS presents a technological showcase at the CHUM with the opening of an automated diabetic retinopathy screening clinic assisted by AI (Artificial Intelligence) with financial support of the Québec government

GlobeNewswire June 6, 2018

DIAGNOS presents a technological showcase at the CHUM with the opening of an automated diabetic retinopathy screening clinic assisted by AI (Artificial Intelligence) with financial support of the Québec government

GlobeNewswire June 5, 2018

DIAGNOS Announces Private Placement and Stock Options Grant

GlobeNewswire May 28, 2018

DIAGNOS Sells 10,500,000 Common Shares of Albert Mining Inc.

GlobeNewswire April 6, 2018

DIAGNOS Welcomes Dr. Reid Maclellan to the Board of Directors

GlobeNewswire April 4, 2018

DIAGNOS Announces the Opening of a Screening Clinic at Chaparral’s Health Management Wellness Center for Medicare Beneficiaries

GlobeNewswire March 14, 2018

Following a successful year, DIAGNOS Announces a One-Year Agreement in United Arabs Emirates with a Major Pharmaceutical Company

GlobeNewswire March 7, 2018

After Successful Screening of 2,500 patients as part of a Pilot Project with Kanhoor Medical Co, DIAGNOS will Now Screen 35,000 patients in the Kingdom of Saudi Arabia

GlobeNewswire February 27, 2018

Arrowhead Business and Investment Decisions Initiates Analyst Coverage of DIAGNOS

GlobeNewswire January 25, 2018

DIAGNOS Announces that the Next Release of its CARA Artificial Intelligence Platform Will Rely on Blockchain Technology for Security Control of Medical Records

GlobeNewswire January 17, 2018

DIAGNOS Announces the Management of the Flagship Nuevo Yo Program by Novo Nordisk

GlobeNewswire January 10, 2018

DIAGNOS Successfully Passed ISO Annual Surveillance Audit

MarketWire Canada December 19, 2017

DIAGNOS Receives Support from Export Development Canada (EDC) for the Issuance of a Performance Bond for the ISSSTE Contract

Marketwired December 6, 2017

DIAGNOS Hires Investor Relation Firm Arrowhead Business and Investment Decisions, LLC and Grants Stock Options

MarketWire Canada November 29, 2017

DIAGNOS Announces a Second Contract for Its Cardio Platform with a Multinational Pharmaceutical Company and the Resignation of a Director

MarketWire Canada November 22, 2017